Cor Vasa 2010, 52(7-8):409-410 | DOI: 10.33678/cor.2010.111

The diagnosis and management of hypertrophic cardiomyopathy

Josef Veselka

Kardiologické oddělení, Kardiovaskulární centrum, Fakultní nemocnice Motol, Česká republika

Hypertrophic cardiomyopathy (HCM) is characterized by a thickened myocardium or increased cardiac mass in the absence of an underlying condition such as arterial hypertension or heart valve disease that may have caused this abnormity. About half to two thirds of HCM patients have intraventricular obstruction, most often subaortic one. The most common diagnostic tool is echocardiography. Pharmacotherapy is only initiated in symptomatic patients. Non-responders with obstructive forms of HCM may have myectomy or alcohol septal ablation. Patients with risk factors for sudden death have cardioverter-defibrillator devices implanted.

Keywords: Hypertrophic cardiomyopathy; Obstruction; Septal ablation; Myectomy

Published: July 1, 2010  Show citation